Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives.

Human pluripotent stem cells (hPSCs) are potential sources of cells for modeling disease and development, drug discovery, and regenerative medicine. However, it is important to identify factors that may impact the utility of hPSCs for these applications. In an unbiased analysis of 205 hPSC and 130 somatic samples, we identified hPSC-specific epigenetic and transcriptional aberrations in genes subject to X chromosome inactivation (XCI) and genomic imprinting, which were not corrected during directed differentiation. We also found that specific tissue types were distinguished by unique patterns of DNA hypomethylation, which were recapitulated by DNA demethylation during in vitro directed differentiation. Our results suggest that verification of baseline epigenetic status is critical for hPSC-based disease models in which the observed phenotype depends on proper XCI or imprinting and that tissue-specific DNA methylation patterns can be accurately modeled during directed differentiation of hPSCs, even in the presence of variations in XCI or imprinting.

[1]  Mike J. Mason,et al.  Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. , 2009, Cell stem cell.

[2]  Michael J. Ziller,et al.  Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines , 2011, Cell.

[3]  K. Eggan,et al.  Erosion of dosage compensation impacts human iPSC disease modeling. , 2012, Cell stem cell.

[4]  Wei Huang,et al.  Insulin‐like growth factor‐2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer , 2011, The Prostate.

[5]  Jun S. Song,et al.  Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells , 2011, Nature Cell Biology.

[6]  J. Lawrence,et al.  X‐inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected , 2008, Journal of cellular physiology.

[7]  Jian-Bing Fan,et al.  Human embryonic stem cells have a unique epigenetic signature. , 2006, Genome research.

[8]  Jennifer A. Erwin,et al.  Derivation of Pre-X Inactivation Human Embryonic Stem Cells under Physiological Oxygen Concentrations , 2010, Cell.

[9]  Cory Y. McLean,et al.  GREAT improves functional interpretation of cis-regulatory regions , 2010, Nature Biotechnology.

[10]  D. Pinto,et al.  A novel approach identifies new differentially methylated regions (DMRs) associated with imprinted genes. , 2011, Genome research.

[11]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[12]  C. Mummery,et al.  Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines. , 2007, Genome research.

[13]  Fred H. Gage,et al.  Transcriptional Signature and Memory Retention of Human-Induced Pluripotent Stem Cells , 2009, PloS one.

[14]  R. Stewart,et al.  Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells , 2011, Nature.

[15]  J. Lawrence,et al.  X‐Inactivation Status Varies in Human Embryonic Stem Cell Lines , 2005, Stem cells.

[16]  K. Plath,et al.  Female human iPSCs retain an inactive X chromosome. , 2010, Cell stem cell.

[17]  Yue-zhong Wu,et al.  Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome. , 2007, Human molecular genetics.

[18]  Julie V. Harness,et al.  Equivalence of Conventionally-Derived and Parthenote-Derived Human Embryonic Stem Cells , 2011, PloS one.

[19]  Jeannie T. Lee,et al.  X-chromosome epigenetic reprogramming in pluripotent stem cells via noncoding genes. , 2011, Seminars in cell & developmental biology.

[20]  David J. Anderson,et al.  The bHLH Transcription Factors OLIG2 and OLIG1 Couple Neuronal and Glial Subtype Specification , 2002, Cell.

[21]  H. Vaziri,et al.  Suppression of the Imprinted Gene NNAT and X-Chromosome Gene Activation in Isogenic Human iPS Cells , 2011, PloS one.

[22]  Kwang-Soo Kim,et al.  Hemangioblastic Derivatives from Human Induced Pluripotent Stem Cells Exhibit Limited Expansion and Early Senescence , 2010, Stem cells.

[23]  L. Lefebvre,et al.  Developmental regulation of somatic imprints. , 2011, Differentiation; research in biological diversity.

[24]  P. Stanier,et al.  The effects of culture on genomic imprinting profiles in human embryonic and fetal mesenchymal stem cells , 2011, Epigenetics.

[25]  Chia-Lin Wei,et al.  Dynamic changes in the human methylome during differentiation. , 2010, Genome research.

[26]  M. Pellegrini,et al.  X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations , 2008, Proceedings of the National Academy of Sciences.

[27]  Fred H. Gage,et al.  A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells , 2010, Cell.

[28]  R. Rowntree,et al.  X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells , 2008, Proceedings of the National Academy of Sciences.

[29]  R. Jirtle,et al.  Metastable Epialleles, Imprinting, and the Fetal Origins of Adult Diseases , 2007, Pediatric Research.

[30]  Bernhard M. Schuldt,et al.  A bioinformatic assay for pluripotency in human cells , 2011, Nature Methods.

[31]  U. Suter,et al.  The Protooncogene Ski Controls Schwann Cell Proliferation and Myelination , 2004, Neuron.

[32]  M. Carpenter,et al.  Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation , 2005, Glia.

[33]  R. Pedersen,et al.  Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines. , 2007, Human molecular genetics.

[34]  C. Lengner,et al.  Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs , 2010, Proceedings of the National Academy of Sciences.

[35]  Gabriel Kolle,et al.  A Continuum of Cell States Spans Pluripotency and Lineage Commitment in Human Embryonic Stem Cells , 2009, PloS one.

[36]  Thomas Vierbuchen,et al.  Induction of human neuronal cells by defined transcription factors , 2011, Nature.

[37]  M. Esteller,et al.  Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome , 2011, Epigenetics.

[38]  Julie V. Harness,et al.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. , 2011, Cell stem cell.

[39]  A. Nagy,et al.  Human Induced Pluripotent Stem Cells: The Past, Present, and Future , 2011, Clinical pharmacology and therapeutics.

[40]  E. Kirkness,et al.  Somatic coding mutations in human induced pluripotent stem cells , 2011, Nature.

[41]  S. Uribe-Lewis,et al.  Molecular mechanisms of genomic imprinting and clinical implications for cancer , 2011, Expert Reviews in Molecular Medicine.

[42]  G. Daley,et al.  Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. , 2010, Cell stem cell.

[43]  G. Churchill,et al.  Characterization of human embryonic stem cell lines by the International Stem Cell Initiative , 2007, Nature Biotechnology.

[44]  N. Jareborg,et al.  Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Segars,et al.  Imprinting disorders and assisted reproductive technology , 2010, Current opinion in endocrinology, diabetes, and obesity.

[46]  Philippe Rigault,et al.  A novel, high-performance random array platform for quantitative gene expression profiling. , 2004, Genome research.

[47]  O. Dreesen,et al.  Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase. , 2011, Cell stem cell.

[48]  B. Migeon,et al.  Species differences in TSIX/Tsix reveal the roles of these genes in X-chromosome inactivation. , 2002, American journal of human genetics.

[49]  Tamar Dvash,et al.  Variations of X Chromosome Inactivation Occur in Early Passages of Female Human Embryonic Stem Cells , 2010, PloS one.

[50]  T. Graf.  Faculty Opinions recommendation of Induction of pluripotent stem cells from adult human fibroblasts by defined factors. , 2007 .

[51]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.